Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Pancreatic neuroendocrine tumors (PNETs) are very rare, accounting for 1-2% of all
pancreatic neoplasms. They are classified into functioning and non-functioning and their …

Pancreatic neuroendocrine tumors (PNETs) are rare and represent a heterogeneous
disease. PNET can be functioning or non-functioning with different clinical presentations and …

Pancreatic neuroendocrine neoplasms (pNEN) are rare malignancies arising from
neuroendocrine cells of the pancreas. Functional tumors can present with specific clinical …

Pancreatic neuroendocrine tumors (PNETs) account for only 3% of pancreatic malignancies,
but have an increasing incidence, currently 0.3 to 0.4 per 100,000. 1–3 They are notably …

Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show peculiar clinical and histomorphological features …

Imaging of gastroenteropancreatic neuroendocrine tumors can be broadly divided into
anatomic and functional techniques. Anatomic imaging determines the local extent of the …

Pancreatic neuroendocrine tumors (pNETs) represent about 7% of all NETs, 8.7% of
gastroenteropancreatic NETs (GEP-NETs) and 1–2% of all pancreatic neoplasms. In the last …

Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show characteristic clinical, histomorphologic, and …

Purpose To present the state-of-art of radiomics in the context of pancreatic neuroendocrine
tumors (PanNETs), with a focus on the methodological and technical approaches used, to …